Champions Oncology, Inc. (CSBR)
Grows human tumors in mice to help pharmaceutical companies test cancer drugs faster.
$5.53-0.09%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-10.2%
The outlook
Champions Oncology is trading near its 52-week low, well below both its 50- and 200-day moving averages, signaling sustained downward pressure. Analyst coverage appears thin based on the data provided. The stock sits in the lower portion of its yearly range with a bearish sentiment score.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Market cap
$76.8M
52-wk high
$8.74
52-wk low
$5.39
50-day avg
$6.04
200-day avg
$6.32
Trailing P/E
—